Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBIT Margin (2020 - 2025)

Historic EBIT Margin for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to 27.83%.

  • PROCEPT BioRobotics' EBIT Margin rose 105900.0% to 27.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.85%, marking a year-over-year increase of 224200.0%. This contributed to the annual value of 43.04% for FY2024, which is 371200.0% up from last year.
  • According to the latest figures from Q3 2025, PROCEPT BioRobotics' EBIT Margin is 27.83%, which was up 105900.0% from 28.02% recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' EBIT Margin ranged from a high of 27.83% in Q3 2025 and a low of 166.02% during Q4 2021
  • In the last 5 years, PROCEPT BioRobotics' EBIT Margin had a median value of 77.41% in 2023 and averaged 87.81%.
  • Its EBIT Margin has fluctuated over the past 5 years, first surged by 3733900bps in 2021, then plummeted by -56700bps in 2023.
  • Over the past 5 years, PROCEPT BioRobotics' EBIT Margin (Quarter) stood at 166.02% in 2021, then skyrocketed by 37bps to 105.31% in 2022, then skyrocketed by 36bps to 67.82% in 2023, then skyrocketed by 57bps to 28.89% in 2024, then increased by 4bps to 27.83% in 2025.
  • Its EBIT Margin stands at 27.83% for Q3 2025, versus 28.02% for Q2 2025 and 39.67% for Q1 2025.